📰 Evofem Bioscience News
Page 2 - Evofem Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evofem Bioscience. Real-time updates on events, politics, business and more.
August 3, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced the appointment of Jenny Yip, a Managing Partner at life sciences investment fund...
August 1, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced that the last subject has completed her last visit in EVOGUARD, the Companys...
July 29, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM), a womens healthcare company, today commended the U.S. Department of Health and Human Services,...
July 26, 2022
Evocative direct-to-consumer (DTC) campaign has received 12 healthcare and communications industry awards to date and has recently been shortlisted for four...
July 25, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has developed a new educational birth control chart that provides high-level...
July 22, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM), a womens healthcare company, today applauded the 228 members of the U.S. House of Representatives...
July 12, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the Journal of Therapeutic Advances in Reproductive Health has published...
June 30, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) announced today that the United States Patent and Trademark Office (USPTO) issued to the Company a...
June 28, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it has reached an agreement with one of the nations largest pharmacy benefit managers...
June 16, 2022
/PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial...